CRISPR Therapeutics
CRSP
#3527
Rank
S$5.25 B
Marketcap
S$54.15
Share price
4.61%
Change (1 day)
-24.87%
Change (1 year)

EPS for CRISPR Therapeutics (CRSP)

EPS in 2026 (TTM): S-$6.09

According to CRISPR Therapeutics's latest financial reports the company's current EPS (TTM) is S-$6.11. In 2025 the company made an earnings per share (EPS) of S-$8.41 a decrease over its 2024 EPS that were of S-$5.63.

EPS history for CRISPR Therapeutics from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$6.09-27.57%
2025S-$8.4149.2%
2024S-$5.63
2022S-$10.79-267.74%
2021S$6.43
2019S$1.43-132.36%
2018S-$4.42

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
S-$1.74-71.52%๐Ÿ‡บ๐Ÿ‡ธ USA